Equity Analysis /
United States of America

US : Biogen Inc. - BIIB | CMS Proposes Highly Restrictive Coverage w/ Evidence Development (CED) Plans for Aduhelm

    Danielle Brill
    CGS-CIMB
    12 January 2022
    Published by